MENU
ENTA
AS OF
Dec 24 closing price
Price
$16.60
Change
+$0.89 (+5.67%)
Capitalization
479.12M
46 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ENTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enanta Pharmaceuticals (ENTA) Ownership - Who owns Enanta Pharmaceuticals?

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
479.12M
P/E Ratio
N/A
Total Cash
188.86M
Projected Growth
N/A
Total Debt
57.9M
Revenue
65.32M
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash/Share
6.54
Total Debt/Equity
N/A
Revenue/Share
3.06 USD as % of share price

Fundamentals

ENTA
Capitalization
479M
P/E Ratio
N/A
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash
189M
Total Cash/Share
6.54
Total Debt
57.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.06%
Revenue
65.3M
ROE
N/A
Book Value
64.7M
P/B Ratio
7.40
Cash Flow
N/A
Earnings
-3.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
214K
Current Ratio
4.21
Current Revenue Per Employee
126041.66
Dividends Per Share - Security
N/A
EBITDA
-71.28M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.91
Shares Held By Institutions
278M
Shares Outstanding - Current
28.9M
Total Liabilities
216M
Total Volume MTD
N/A
Value
-1
Gain YTD
188.696
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ENTA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENTA showed earnings on November 17, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ENTA
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com